These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 30102479)
21. Current issues on sublingual allergen-specific immunotherapy in children with asthma and allergic rhinitis. Živković Z; Djurić-Filipović I; Živanović S Srp Arh Celok Lek; 2016; 144(5-6):345-50. PubMed ID: 29648760 [TBL] [Abstract][Full Text] [Related]
22. Sublingual immunotherapy for allergic rhinitis. Wilson DR; Torres LI; Durham SR Cochrane Database Syst Rev; 2003; (2):CD002893. PubMed ID: 12804442 [TBL] [Abstract][Full Text] [Related]
23. Oral allergy syndrome in patients with airborne pollen allergy treated with specific immunotherapy. Czarnecka-Operacz M; Jenerowicz D; Silny W Acta Dermatovenerol Croat; 2008; 16(1):19-24. PubMed ID: 18358104 [TBL] [Abstract][Full Text] [Related]
24. Immunotherapy in allergic rhinitis and lower airway outcomes. Cardona V; Luengo O; Labrador-Horrillo M Allergy; 2017 Jan; 72(1):35-42. PubMed ID: 27439141 [TBL] [Abstract][Full Text] [Related]
25. Semi-depot house-dust mite allergen extract for Chinese with allergic rhinitis and asthma. Li X; Wang X; Lin X; Xu G; Tao Z; Jiang W; Cheng L; Guo Y; Lai H; Shen K Am J Rhinol Allergy; 2016 May; 30(3):201-8. PubMed ID: 27216351 [TBL] [Abstract][Full Text] [Related]
26. Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma. Passalacqua G; Canonica GW; Bagnasco D Curr Allergy Asthma Rep; 2016 Nov; 16(12):88. PubMed ID: 27957697 [TBL] [Abstract][Full Text] [Related]
27. The Cost-Effectiveness of Allergen Immunotherapy Compared with Pharmacotherapy for Treatment of Allergic Rhinitis and Asthma. Cox LS; Murphey A; Hankin C Immunol Allergy Clin North Am; 2020 Feb; 40(1):69-85. PubMed ID: 31761122 [TBL] [Abstract][Full Text] [Related]
28. Long-term efficacy of standardised specific subcutaneous immunotherapy in children with persistent allergic rhinitis due to multiple allergens including house dust mites. Song Y; Long J; Wang T; Xie J; Wang M; Tan G J Laryngol Otol; 2018 Mar; 132(3):230-235. PubMed ID: 29374499 [TBL] [Abstract][Full Text] [Related]
29. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. Kiel MA; Röder E; Gerth van Wijk R; Al MJ; Hop WC; Rutten-van Mölken MP J Allergy Clin Immunol; 2013 Aug; 132(2):353-60.e2. PubMed ID: 23651609 [TBL] [Abstract][Full Text] [Related]
30. [New administration routes for immunotherapy]. Martorell Aragonés A Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377 [TBL] [Abstract][Full Text] [Related]
31. Effectiveness of immunotherapy in children depends on place of living - A pilot study. Pawlowski M; Jerzynska J; Podlecka D; Stelmach W; Majak P; Stelmach I Allergol Immunopathol (Madr); 2017; 45(3):272-275. PubMed ID: 27908569 [TBL] [Abstract][Full Text] [Related]
32. One century of allergen-specific immunotherapy for respiratory allergy. Incorvaia C; Frati F Immunotherapy; 2011 May; 3(5):629-35. PubMed ID: 21554092 [TBL] [Abstract][Full Text] [Related]
33. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis]. Pfaar O; Hörmann K; Klimek L MMW Fortschr Med; 2006 Feb; 148(5):28-32. PubMed ID: 16518935 [TBL] [Abstract][Full Text] [Related]
34. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy. Cochard MM; Eigenmann PA J Allergy Clin Immunol; 2009 Aug; 124(2):378-9. PubMed ID: 19541352 [No Abstract] [Full Text] [Related]
35. Sublingual or subcutaneous immunotherapy for allergic rhinitis? Durham SR; Penagos M J Allergy Clin Immunol; 2016 Feb; 137(2):339-349.e10. PubMed ID: 26853126 [TBL] [Abstract][Full Text] [Related]
36. The role of allergy immunotherapy in the treatment of asthma. Mener DJ; Lin SY Curr Opin Otolaryngol Head Neck Surg; 2016 Jun; 24(3):215-20. PubMed ID: 27159540 [TBL] [Abstract][Full Text] [Related]
37. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis. Rossi RE; Monasterolo G; Coco G; Operti D Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987 [TBL] [Abstract][Full Text] [Related]
38. Specific immunotherapy in allergic rhinitis. Mortuaire G; Michel J; Papon JF; Malard O; Ebbo D; Crampette L; Jankowski R; Coste A; Serrano E Eur Ann Otorhinolaryngol Head Neck Dis; 2017 Sep; 134(4):253-258. PubMed ID: 28684084 [TBL] [Abstract][Full Text] [Related]
39. Treating allergic rhinitis with depot-steroid injections increase risk of osteoporosis and diabetes. Aasbjerg K; Torp-Pedersen C; Vaag A; Backer V Respir Med; 2013 Dec; 107(12):1852-8. PubMed ID: 24090789 [TBL] [Abstract][Full Text] [Related]
40. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Wilson DR; Lima MT; Durham SR Allergy; 2005 Jan; 60(1):4-12. PubMed ID: 15575924 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]